Potential oral manifestations of cardiovascular drugs

Oral Diseases

Volumn 16, Issue 8, 2010, Pages 769-773

  Habbab, K M ^a,b   Moles, D R ^a,c   Porter, S R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

^c PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

Apthae; Cardiac; Drugs; Dysgeusia; Lichen; Xerostomia

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IVABRADINE; LOOP DIURETIC AGENT; STATIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BURNING MOUTH SYNDROME; CARDIOVASCULAR RISK; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; DYSGEUSIA; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; LICHEN; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; PRIORITY JOURNAL; SAUDI ARABIA; VALVULAR HEART DISEASE; XEROSTOMIA;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIURETICS; DYSGEUSIA; FEMALE; GINGIVAL DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; LICHENOID ERUPTIONS; MALE; MIDDLE AGED; MOUTH DISEASES; PARESTHESIA; PLATELET AGGREGATION INHIBITORS; VASODILATOR AGENTS; XEROSTOMIA; YOUNG ADULT;

EID: 77958172779     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01686.x     Document Type: Article

References (18)

1. Abdollahi M, Rahimi R, Radfar M (2008). Current opinion on drug-induced oral reactions: a comprehensive review. J Contemp Dent Pract 9: 1-15.
2. Abernethy DR, Flockhart DA (2000). Molecular basis of cardiovascular drug metabolism-implications for predicting clinically important drug interactions. Circulation 101: 1749-1753.
3. Aguilar D, Solomon SD (2006). ACE inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: an emerging theme. Drugs 66: 1169-1177.
4. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY et al (2004). Diabetes mellitus in Saudi Arabia. Saudi Med J 25: 1603-1610.
5. Al-Nozha MM, Abdullah M, Arafah MR et al (2007). Hypertension in Saudi Arabia. Saudi Med J 28: 77-84.
6. Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI (2005). The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care 28: 2261-2266.
7. Kuechle MK, Hutton KP, Muller SA (1994). Angiotensin-converting enzyme inhibitor-induced pemphigus: three case reports and literature review. Mayo Clin Proc 69: 1166-1171.
8. Marshall RI, Bartold PM (1998). Medication induced gingival overgrowth. Oral Dis 4: 130-151.
9. McCartan BE, McCreary CE (1997). Oral lichenoid drug eruptions. Oral Dis 3: 58-63.
10. Nakagawa K, Ishizaki T (2000). Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine. Pharmacol Ther 86: 1-28.
11. Persson RE, Izutsu KT, Truelove EL, Persson R (1991). Differences in salivary flow rates in elderly subjects using xerostomatic medications. Oral Surg Oral Med Oral Pathol 72: 42-46.
12. Porter S, Scully C (2000). Adverse drug reactions in the mouth. Clin Dermatol 18: 525-532.
13. Shinkai RS, Hatch JP, Schmidt CB, Sartori EA (2006). Exposure to the oral side effects of medication in a community-based sample. Spec Care Dentist 26: 116-120.
14. Smith RG, Burtner AP (1994). Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist 14: 96-102.
15. Sreebny LM, Schwartz SS (1997). A reference guide to drugs and dry mouth. Gerodontology 14: 33-47.
16. Sreebny LM, Yu A, Green A, Valdini A (1992). Xerostomia in diabetes mellitus. Diabetes Care 15: 900-904.
17. Streckfus CF (1995). Salivary function and hypertension: a review of the literature and a case report. J Am Dent Assoc 126: 1012-1017.
18. Tran C, Knowles SR, Liu BA, Shear NH (1998). Gender differences in adverse drug reactions. J Clin Pharmacol 38: 1003-1009.